{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 51.8671,
  "market_cap": 230470402048,
  "revenue_ttm": 49539301433.42396,
  "net_income_ttm": 16288951396.693645,
  "ocf_ttm": 19430020908.023533,
  "capex_ttm": 9862873503.318285,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1393711268.3573074,
  "total_debt": 15887272476.125298,
  "cash_and_equivalents": 5114460441.140461,
  "book_value_ttm": 26668089835.435646,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4471674,
  "dividend_yield": 339.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2026-01-02T18:28:46Z"
}